Effect of the GSK2245035 on the Allergen-induced Asthmatic Response
Clinical trial NCT02833974 · COMPLETED
Trial details
- NCT number
- NCT02833974
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2018-02-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.